Document is current
Any future updates will be listed below
-
Authors
Barrett, Thomas F. https://orcid.org/0000-0002-6058-1404
Patel, Bhuvic https://orcid.org/0000-0001-8062-7310
Khan, Saad M. https://orcid.org/0000-0002-1385-2056
Mullins, Riley D. Z. https://orcid.org/0000-0002-7205-9971
Yim, Aldrin K. Y.
Pugazenthi, Sangami https://orcid.org/0000-0002-5179-5232
Mahlokozera, Tatenda
Zipfel, Gregory J.
Herzog, Jacques A.
Chicoine, Michael R.
Wick, Cameron C.
Durakovic, Nedim
Osbun, Joshua W.
Shew, Matthew
Sweeney, Alex D.
Patel, Akash J.
Buchman, Craig A.
Petti, Allegra A. https://orcid.org/0000-0001-6884-6107
Puram, Sidharth V. https://orcid.org/0000-0003-3543-889X
Kim, Albert H. https://orcid.org/0000-0002-1751-8493
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (T32DC000022)
- License Information
-
More Information
Article History
Received: 3 November 2022
Accepted: 10 October 2023
First Online: 12 January 2024
Competing interests
: Regarding potential conflicts of interest, A.H.K. is a consultant for Monteris Medical and has received non-related research grants from Stryker and Collagen Matrix for study of a dural substitute. C.C.W. is a consultant for Stryker and Cochlear Ltd. C.A.B. is a consultant for Advanced Bionics, Cochlear, Envoy, and IotaMotion, and also has equity interest in Advanced Cochlear Diagnostics L.L.C. The remaining authors declare no competing interests.
